ABIONYX Pharma Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 10, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	111	34	36	43	57	22
Market Cap Growth	220.95%	-5.22%	-16.22%	-24.36%	161.10%	248.58%
Enterprise Value	111	32	38	43	53	15
Last Close Price	3.10	0.99	1.10	1.60	2.04	0.68
PS Ratio	29.83	9.07	8.94	9.23	100.22	-
PB Ratio	23.46	5.49	5.24	6.76	6.34	3.66
P/TBV Ratio	2435.21	20.02	16.83	28.22	12.95	3.69
EV/Sales Ratio	29.53	8.60	9.45	9.31	93.31	-
Debt / Equity Ratio	0.75	0.37	0.43	0.56	0.46	0.00
Net Debt / Equity Ratio	0.14	-0.06	-0.09	0.00	-0.28	-1.38
Net Debt / EBITDA Ratio	-0.16	0.11	0.22	0.01	0.51	3.10
Net Debt / FCF Ratio	-0.20	0.13	0.19	0.01	0.43	13.01
Asset Turnover	0.30	0.32	0.30	0.28	0.04	-
Inventory Turnover	17.39	17.16	21.86	28.49	-	-
Quick Ratio	1.30	1.49	1.68	1.39	1.86	2.78
Current Ratio	1.40	1.58	1.75	1.49	1.93	2.79
Return on Equity (ROE)	-61.53%	-56.76%	-46.62%	-47.14%	-67.28%	-28.37%
Return on Assets (ROA)	-20.47%	-19.67%	-13.91%	-13.64%	-23.16%	-18.07%
Return on Invested Capital (ROIC)	-74.81%	-62.69%	-47.57%	-55.39%	-228.97%	-
Return on Capital Employed (ROCE)	-50.90%	-45.40%	-31.30%	-38.30%	-39.50%	-44.40%
Earnings Yield	-3.56%	-10.62%	-8.48%	-8.68%	-8.61%	-7.76%
FCF Yield	-2.84%	-8.97%	-9.16%	-7.27%	-10.14%	-2.89%
Buyback Yield / Dilution	-11.34%	-14.80%	-4.95%	-12.41%	-5.92%	-11.21%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.